Hemophilia Treatment Centers (HTC) that receive HRSA grant funding are expected to provide optimal care using a multi-disciplinary team approach that provides accessible, family-centered, continuous, comprehensive, coordinated, and culturally effective care for individuals with hemophilia and other bleeding disorders.The program is authorized under section 501(a)(2) of the Social Security Act. For more information, see Hemophilia Treatment Centers.
Check your registration. Search the covered entities database to make sure you are not already registered.
Be aware of the latest registration dates and deadlines. The current registration periods are listed on the top right corner of this page, along with a link to the OPA database and registration forms. The registration forms are open only during the registration periods.
Collect needed information. You will need to supply your Medicaid billing number or National Provider Identifier (if you will be billing Medicaid for drugs purchased at 340B prices) and grant number (if applicable), as well as basic information such as your mailing address and a point of contact.
Identify your Authorizing Official. Only an individual who can bind the organization to a contract, such as a CEO, COO, CFO, clinic administrator, or program manager can submit the 340B on-line registration, although you can designate another employee (not a consultant or contractor) to be the primary contact.
Prepare to complete in one session. The authorizing official must complete the on-line registration in one session. If left inactive, the session will close and you will need to start over.
Once approved, an e-mail will be sent to the address provided on your registration. The message will confirm your successful enrollment in the 340B program and will include the date on which you can begin purchasing 340B discounted drugs and the 340B identification number that manufacturers, wholesalers and others will use to verify your participation in the 340B program